𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multicenter randomised phase-III trial to compare tumour nephrectomy plus adjuvant autologous tumour cell-lysate vaccine versus tumour nephrectomy without adjuvant treatment for renal cell carcinoma PT2-3BPN0-3M0

✍ Scribed by C. Dochn; A. Richter; W. Lehmacher; D. Jocham

Book ID
118644546
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
179 KB
Volume
2
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Autologous tumour cell vaccine may reduc
Autologous tumour cell vaccine may reduce risk of tumour progression in people with primary renal cell carcinoma: Abstracted from: Jocham D, Richter A, Hoffmann L et al. Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. Lancet 2004;363:594–599.
✍ Chris Coppin πŸ“‚ Article πŸ“… 2004 πŸ› Elsevier Science 🌐 English βš– 234 KB